CIK 0002093101
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Atrium Therapeutics, Inc.
Sign in to watch- Ticker
- RNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 394639499
- Phone
- +1 619-876-0700
- Business address
- 10578 SCIENCE CENTER DRIVE, SUITE 125, SAN DIEGO, CA
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
Page 1 of 1 · 8 filings